Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
narazaciclib (HX301)
i
Other names:
HX301, ON 123300, ON-123300, HX 301, ON123300
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
HanX Biopharma, Traws Pharma
Drug class:
CDK4 inhibitor, CDK6 inhibitor, CSF-1R inhibitor, ARK5 inhibitor
Related drugs:
‹
palbociclib (222)
abemaciclib (80)
ribociclib (62)
dalpiciclib (11)
DSP-2033 (8)
trilaciclib (3)
PRT3645 (3)
RGT-419B (2)
XZP 3287 (2)
TQB3616 (2)
CS3002 (1)
FCN-437 (1)
GLR2007 (1)
PF-07220060 (1)
PF-06873600 (1)
G1T38 (1)
BPI-16350 (1)
AM-5992 (0)
BPI-1178 (0)
FLX925 (0)
FN-1501 (0)
HS-10342 (0)
PF-07224826 (0)
SPH4336 (0)
SRX3177 (0)
SYH2043 (0)
TY-0540 (0)
TY-302 (0)
Undisclosed CDK4/6 inhibitor (0)
XH-30002 (0)
NUV-422 (0)
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
palbociclib (222)
abemaciclib (80)
ribociclib (62)
dalpiciclib (11)
DSP-2033 (8)
trilaciclib (3)
PRT3645 (3)
RGT-419B (2)
XZP 3287 (2)
TQB3616 (2)
CS3002 (1)
FCN-437 (1)
GLR2007 (1)
PF-07220060 (1)
PF-06873600 (1)
G1T38 (1)
BPI-16350 (1)
AM-5992 (0)
BPI-1178 (0)
FLX925 (0)
FN-1501 (0)
HS-10342 (0)
PF-07224826 (0)
SPH4336 (0)
SRX3177 (0)
SYH2043 (0)
TY-0540 (0)
TY-302 (0)
Undisclosed CDK4/6 inhibitor (0)
XH-30002 (0)
NUV-422 (0)
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MYC overexpression
Hepatocellular Cancer
MYC overexpression
Hepatocellular Cancer
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
NUAK1 overexpression
Hepatocellular Cancer
NUAK1 overexpression
Hepatocellular Cancer
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login